Antares Pharma Inc ATRS:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 05/17/22 EDT
5.58UNCH (UNCH)
Volume
19,957
Close
5.58quote price arrow up+0.01 (+0.18%)
Volume
1,388,614
52 week range
3.11 - 5.59
Loading...
  • Open5.58
  • Day High5.58
  • Day Low5.57
  • Prev Close5.58
  • 52 Week High5.59
  • 52 Week High Date05/04/22
  • 52 Week Low3.11
  • 52 Week Low Date01/28/22

Key Stats

  • Market Cap953.34M
  • Shares Out170.85M
  • 10 Day Average Volume3.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change56.3

KEY STATS

  • Open5.58
  • Day High5.58
  • Day Low5.57
  • Prev Close5.58
  • 52 Week High5.59
  • 52 Week High Date05/04/22
  • 52 Week Low3.11
  • 52 Week Low Date01/28/22
  • Market Cap953.34M
  • Shares Out170.85M
  • 10 Day Average Volume3.36M
  • Dividend-
  • Dividend Yield-
  • Beta1.14
  • YTD % Change56.3

RATIOS/PROFITABILITY

  • EPS (TTM)0.27
  • P/E (TTM)21.02
  • Fwd P/E (NTM)60.00
  • EBITDA (TTM)31.243M
  • ROE (TTM)31.40%
  • Revenue (TTM)183.98M
  • Gross Margin (TTM)62.89%
  • Net Margin (TTM)25.16%
  • Debt To Equity (MRQ)11.23%

EVENTS

  • Earnings Date08/03/2022(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Antares Pharma Inc

There is no recent news for this security.

Content From Our Affiliates

There is no recent news for this security.

Profile

MORE
Antares Pharma, Inc. is a specialty pharmaceutical company. The Company is focused primarily on the development and commercialization of pharmaceutical products and technologies that address patient needs in targeted therapeutic areas. The Company develops, manufactures, and commercializes, for itself or with partners, therapeutic products using its drug delivery systems. The Company products include XYOSTED (testosterone enanthate) injection, NOCDURNA (desmopressin acetate)...
Leonard Jacob M.D., Ph.D.
Independent Chairman of the Board
Robert Apple CPA
President, Chief Executive Officer, Director
Fred Powell CPA
Chief Financial Officer, Executive Vice President
Peter Graham
Executive Vice President, Chief Compliance Officer - Human Resources, General Counsel, Corporate Secretary
Peter Richardson
Executive Vice President, Research and Development and Chief Medical Officer
Address
100 Princeton South, Suite 300
Ewing, NJ
08628
United States

Top Peers

SYMBOLLASTCHG%CHG
HSKA
Heska Corp
97.55UNCHUNCH
SIGA
SIGA Technologies Inc
7.28UNCHUNCH
EGRX
Eagle Pharmaceuticals Inc
47.07+1.90+4.21%
TVTX
Travere Therapeutics Inc
25.68UNCHUNCH
ANIP
ANI Pharmaceuticals Inc
29.73+0.96+3.34%